TRXC Apr 2020 1.500 call
| Previous Close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 1.50 |
| Expire Date | 2020-04-17 |
| Day's Range | 0.0500 - 0.0500 |
| Contract Range | N/A |
| Volume | 20 |
| Open Interest | N/A |
- Business Wire
TransEnterix Announces One-for-Thirteen Reverse Stock Split of its Common Stock
TransEnterix, Inc. (NYSE American: TRXC) today announced that, following approval of a reverse stock split range and authorized share reduction by stockholders at a special meeting of stockholders earlier today, the TransEnterix’s Board of Directors determined to effect a reverse stock split of TransEnterix’s common stock at a ratio of one-for-thirteen. The applicable Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, was filed with the Delaware Secretary of State today and will become effective at 5:00 p.m. Eastern Time on December 11, 2019.
- Thomson Reuters StreetEvents
Edited Transcript of TRXC earnings conference call or presentation 12-Nov-19 9:30pm GMT
Q3 2019 Transenterix Inc Earnings Call
- Zacks
Simple Market Timing Strategies That Work - December 04, 2019
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
- TEST Business Wire Releases
TransEnterix, Inc. to Host Surgeon Panel Discussion and Senhance Technology Demonstration Event on Friday, December 6, 2019
TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced it will host a surgeon panel discussion and Senhance technology demonstration via live webcast on Friday, December 6, 2019 from 11:00am to 12:00pm ET.
- Simply Wall St.
Was TransEnterix, Inc.'s (NYSEMKT:TRXC) Earnings Decline Part Of A Broader Industry Downturn?
When TransEnterix, Inc. (AMEX:TRXC) announced its most recent earnings (30 September 2019), I did two things: looked...
- Zacks
The Truth About Market Timing - November 14, 2019
In the long-run, does consistent market timing really matter to be a successful investor?
- Zacks
TransEnterix (TRXC) Reports Q3 Loss, Misses Revenue Estimates
TransEnterix (TRXC) delivered earnings and revenue surprises of -28.57% and -56.72%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2019
TransEnterix, Inc. , a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2019 and provided a business update.
- Business Wire
TransEnterix Announces Repayment of Hercules Term Loan and Provides Update on AutoLap Transaction
TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the repayment of all amounts owed under the loan agreement with Hercules Capital, Inc. (“Hercules”) (HTGC) and provided an update on the AutoLap transaction. “We determined it was in the best interests of the Company to pay down the debt and terminate the loan agreement to simplify our balance sheet and provide additional flexibility as the Board of Directors continues to explore the strategic and financing alternatives available to us,” said Anthony Fernando, President and Chief Executive Officer.
- Business Wire
TransEnterix Board of Directors Appoints Anthony Fernando as President and Chief Executive Officer
TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that the Company’s Board of Directors has appointed Anthony Fernando, the Company’s current Chief Operating Officer and Chief Technology Officer, as President and Chief Executive Officer and a member of the Board of Directors, effective November 8, 2019. Mr. Fernando succeeds Todd Pope who is stepping down from his positions as President and Chief Executive Officer.
- Zacks
Earnings Preview: TransEnterix (TRXC) Q3 Earnings Expected to Decline
TransEnterix (TRXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Business Wire
TransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 12, 2019
TransEnterix, Inc. announced today that it plans to release third quarter financial and operating results after the market closes on Tuesday, November 12, 2019.
- Business Wire
TransEnterix Announces Plan for Reverse Stock Split
TransEnterix, Inc. (NYSE American: TRXC) a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that its Board of Directors has approved a proposal, to be submitted to stockholders for approval at a Special Meeting of Stockholders anticipated to be held on December 18, 2019, to authorize the Board of Directors to effect a reverse stock split of the Company’s common stock. The reverse stock split proposal includes a proposed range between 1-for-10 and 1-for-40 shares of outstanding common stock.
- Zacks
The Truth About Market Timing - October 24, 2019
In the long-run, does consistent market timing really matter to be a successful investor?
- Business Wire
TransEnterix Provides a Corporate Update
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has agreed to amend the previously announced AutoLap System Sale Agreement. In addition, the Company announced that it has engaged J.P. Morgan Securities LLC to evaluate strategic alternatives while simultaneously re-directing its operational focus and implementing a restructuring plan to reduce operating expenses.
- Zacks
When Does Market Timing Actually Work? - October 03, 2019
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
- Zacks
The Rise of Robots in Surgery Puts Spotlight on These 3 Stocks
A number of MedTech companies are currently attempting to gain ground within the robotics-aided healthcare market.
- Zacks
The Truth About Market Timing - September 13, 2019
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
- Simply Wall St.
Investors Who Bought TransEnterix (NYSEMKT:TRXC) Shares A Year Ago Are Now Down 88%
Even the best investor on earth makes unsuccessful investments. But it should be a priority to avoid stomach churning...
- Thomson Reuters StreetEvents
Edited Transcript of TRXC earnings conference call or presentation 7-Aug-19 8:30pm GMT
Q2 2019 Transenterix Inc Earnings Call
- Zacks
Yes, You Can Time the Market. Find out How - August 26, 2019
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
